Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension

JAMA

Volumn 276, Issue 23, 1996, Pages 1886-1892

  Curb, J David ^a   Pressel, Sara L ^b,m   Cutler, Jeffrey A ^c   Savage, Peter J ^c   Applegate, William B ^d   Black, Henry ^e   Camel, Greta ^f   Davis, Barry R ^b   Frost, Phillip H ^g   Gonzalez, Nelly ^h   Guthrie, Gordon ⁱ   Oberman, Albert ^j   Rutan, Gail H ^k   Stamler, Jeremiah ^l  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF KENTUCKY   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m Systolic Hypertension Elderly P   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CHLORTALIDONE; DIURETIC AGENT; PLACEBO; RESERPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SYSTOLIC HYPERTENSION;

EID: 10544229794     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.23.1886     Document Type: Article

References (20)

1. Collins R, Peto R, MacMahon S, et al. Blood presssure, stroke, and coronary heart disease. Lancet. 1990;335:827-838.
2. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, I: reduction in mortality of persons with high blood pressure including mild hypertension. JAMA. 1979; 242:2562-2571.
3. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, II. JAMA. 1979;242:2572-2577.
4. Hypertension Detectionand Follow-up Program Cooperative Group. Implications of the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986;29(suppl 1):3-10.
5. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349-1354.
6. Systolic Hypertension in the Elderly Program Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
7. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbon T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients With Hypertension (STOP-Hypertension). Lancet. 1991;338: 1281-1285.
8. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
9. Amery A, Birkenhager, Brixko P, et al. Glucose intolerance during diuretic therapy in elderly hypertensive patients. Postgrad Med J. 1986;62:919-924.
10. Donahue RP, Abbott RD, Wilson PWF. Effect of diuretic use on the development of diabetes mellitus. Harm Metab Res Suppl. 1991;22:46-48.
11. Blohme G, Lapidus L, Lissner L, Lundgren H. Diabetes incidence in users and non-users of antihypertensive drugs in relation to serum insulin, glucose tolerance and degree of adiposity. J Int Med. 1992;231:583-588.
12. Warram JH, Laffel LMB, Vasania P, Christlieb AR, Krolewski AS. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med. 1991;151:1350-1356.
13. Systolic Hypertension in the Elderly Program Cooperative Research Group. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J Clin Epidemiol. 1988;41:1197-1208.
14. Systolic Hypertension in the Elderly Program (SHEP). Baseline characteristics of the randomized SHEP participants. Hypertension. 1991;17 (suppl 2):II-1-II-168.
15. Davis BR, Cutler JA, Gordon DJ, et al, for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens. 1996;9:342-360.
16. Klein R, Moss SE, Klein BEK, DeMets DL. Relation of ocular and systemic factors to survival in diabetics. Arch Intern Med. 1989;149:266-272.
17. Kostis JB, Berge KG, Davis BR, Hawkins CM, Probstfield J, for the SHEP Cooperative Research Group. Effect of atenolol and reserpine on selected events in the Systolic Hypertension in the Elderly Program (SHEP). Am J Hypertens. 1995;8:1147-1153.
18. The Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension. 1993;21:335-343.
19. Lewis EJ, Hunsicker LG, Bain, RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
20. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.